Celebrex Information

Celebrex was approved in the U.S. in January 1999. Celebrex is part of a class of drugs called COX-2 inhibitors, the drugs work by selectively blocking a protein called COX-2 that has been linked to inflammation. Reports linking Celebrex to death and serious side effects began to come in just three months on the market. Individuals looking for pain relief due to arthritis were suffering death, gastrointestinal hemorrhages, cardiovascular problems, kidney and liver damages, heart attacks, stroke, blood clots and ulcers.

Celebrex advertisements claimed that the arthritis medication was safer and gentler on the stomach compared to older NSAIDS. A study performed on Celebrex, called the CLASS study, concluded a "clinically meaningful" safety advantage of Celebrex over older NSAIDS had not in fact been established.

The CLASS study also failed to show that Celebrex worked any more safely than NSAIDS regarding ulcer complications. Celebrex manufacturer then began to make television ads without naming Celebrex to avoid Federal laws requiring side effects to be stated on the advertisements. Both Celebrex maker and rival Vioxx made continuous attempts to have label warnings removed in order to gain the upper hand on one another.

If you have taken Celebrex and have suffered adverse side effects because of it, please contact us today to put you in touch with qualified and experienced Celebrex attorneys in your area.

Select a State.

Make Contact.
After choosing a state, submit your case and we will send it to all the participating attorneys in your area.

Make the Decision.
Based on the responses you receive, choose the attorney with whom you are the most comfortable. Response times may vary.